Sensus Healthcare (SRTS) Net Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - | -25.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.87% |
| Dec 31, 2025 | -372.11% |
| Sep 30, 2025 | -36.11% |
| Jun 30, 2025 | -26.90% |
| Mar 31, 2025 | 64.56% |
| Dec 31, 2024 | -118.87% |
| Sep 30, 2024 | 726.27% |
| Jun 30, 2024 | 492.85% |
| Mar 31, 2024 | -36.25% |
| Dec 31, 2023 | 122.07% |
| Sep 30, 2023 | -88.80% |
| Jun 30, 2023 | -18.33% |
| Mar 31, 2023 | -133.75% |
| Dec 31, 2022 | -544.07% |
| Sep 30, 2022 | 226.37% |
| Jun 30, 2022 | -43.75% |
| Mar 31, 2022 | 1,559.04% |
| Dec 31, 2021 | -53.44% |
| Sep 30, 2021 | 151.88% |
| Jun 30, 2021 | -75.43% |
| Mar 31, 2021 | -131.39% |
| Dec 31, 2020 | -202.11% |
| Sep 30, 2020 | 49.48% |
| Jun 30, 2020 | 21.90% |
| Mar 31, 2020 | 164.15% |
| Dec 31, 2019 | 125.77% |
| Sep 30, 2019 | -149.72% |
| Jun 30, 2019 | 444.62% |
| Mar 31, 2019 | -995.34% |
| Dec 31, 2018 | -242.81% |
| Sep 30, 2018 | 248.49% |
| Jun 30, 2018 | -225.46% |
| Mar 31, 2018 | 71.78% |